Trade Merck KGaA - EUR - MRKd CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.40 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.018641% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | -0.003582% | ||||||||
| Overnight fee time | 22:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | EUR | ||||||||
| Margin | 5.00% | ||||||||
| Stock exchange | Germany | ||||||||
| Commission on trade | 0% |
| Prev. Close | 136.35 |
| Open | 136.35 |
| 1-Year Change | -11.09% |
| Day's Range | 135.15 - 136.7 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Feb 21, 2025 | 135.25 | -0.95 | -0.70% | 136.20 | 136.75 | 134.95 |
| Feb 20, 2025 | 136.35 | 1.30 | 0.96% | 135.05 | 136.45 | 133.15 |
| Feb 19, 2025 | 135.40 | -0.65 | -0.48% | 136.05 | 137.55 | 135.30 |
| Feb 18, 2025 | 136.00 | 0.05 | 0.04% | 135.95 | 136.60 | 135.35 |
| Feb 17, 2025 | 135.55 | 2.70 | 2.03% | 132.85 | 135.75 | 132.85 |
| Feb 14, 2025 | 135.60 | -0.35 | -0.26% | 135.95 | 136.65 | 135.35 |
| Feb 13, 2025 | 136.70 | 1.80 | 1.33% | 134.90 | 136.95 | 134.40 |
| Feb 12, 2025 | 134.60 | 0.60 | 0.45% | 134.00 | 135.05 | 132.60 |
| Feb 11, 2025 | 134.70 | 0.55 | 0.41% | 134.15 | 135.95 | 133.20 |
| Feb 10, 2025 | 135.35 | -4.40 | -3.15% | 139.75 | 140.00 | 134.55 |
| Feb 7, 2025 | 139.65 | -1.30 | -0.92% | 140.95 | 142.50 | 139.65 |
| Feb 6, 2025 | 142.15 | 1.25 | 0.89% | 140.90 | 143.20 | 140.45 |
| Feb 5, 2025 | 140.95 | -0.10 | -0.07% | 141.05 | 141.70 | 140.05 |
| Feb 4, 2025 | 141.20 | -2.60 | -1.81% | 143.80 | 143.90 | 140.50 |
| Feb 3, 2025 | 144.25 | 0.80 | 0.56% | 143.45 | 145.05 | 142.80 |
| Jan 31, 2025 | 146.90 | -4.20 | -2.78% | 151.10 | 151.10 | 146.40 |
| Jan 30, 2025 | 151.30 | 2.85 | 1.92% | 148.45 | 151.45 | 148.45 |
| Jan 29, 2025 | 148.70 | -0.25 | -0.17% | 148.95 | 149.80 | 145.60 |
| Jan 28, 2025 | 149.80 | 1.10 | 0.74% | 148.70 | 154.40 | 148.70 |
| Jan 27, 2025 | 144.95 | 0.35 | 0.24% | 144.60 | 145.60 | 142.40 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Merck - EUR Company profile
About Merck KGaA
Merck KGaA is a Germany-based science and technology company. The Company operates in three business segments: Healthcare, Life Sciences and Electronics. The Healthcare business, which operates in the United States and Canada as EMD Serono, focuses on such therapeutic areas as allergies, fertility, oncology and neurodegenerative diseases, developing drugs, diagnostic substances and medical devices. The Life Sciences business comprises the activities of MilliporeSigma, which provides solutions that facilitate biotechnology and pharmaceutical research. The product range includes laboratory water systems, gene editing tools, cell lines and end-to-end drug manufacturing systems, among others. The Electronics business enables digital living and provides specialty chemicals for various applications, including liquid crystals for electronic displays, materials for integrated circuits, effect pigments for coatings and color cosmetics, as well as functional materials for energy solutions.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Merck KGaA revenues increased 12% to EUR19.69B. Net income applicable to common stockholders increased 54% to EUR3.06B. Revenues reflect Life Science segment increase of 20% to EUR8.99B, Healthcare segment increase of 7% to EUR7.09B, United States (Country) segment increase of 13% to EUR5.25B, Rest of Europe segment increase of 14% to EUR4.03B.
Equity composition
2003 Q1 has been restated to reflect discontinued operations. 01/2007, Rights Issue, 4 new shares for every 29 shares held @ EUR 78 (Factor: 1.015602). 6/2014, 2-for-1 stock split (Factor: 2).
| Industry: | Proprietary & Advanced Pharmaceuticals |
Frankfurter Str. 250
DARMSTADT
HESSEN 64293
DE
News
Microsoft Stock Price Forecast for 2025 and beyond: Third party price target
We assess the likely level of the Microsoft stock price in 5 years, and possible drivers behind the stock’s past performance. Read on...
18:29, 7 February 2025
Ripple XRP price prediction: Third-party price target
Discover the ripple (XRP) price predictions for 2025 and beyond, with analyst price targets and CFDs trading strategies on Capital.com
15:29, 6 February 2025
Apple (AAPL) stock price forecast: third-party price target
We looked at the forecasts for Apple stock in 10 years to see where the price would likely be at that point and the challenges the company could face. Read more.
11:22, 6 February 2025
FARTCOIN price prediction: Third-party price target
Read our FARTCOIN price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:18, 29 January 2025
MELANIA coin ($MELANIA) price prediction: Third party price target
Read our MELANIA crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts.
11:33, 22 January 2025
TRUMP coin ($TRUMP) price prediction: third-party price target
Read our TRUMP crypto price prediction for 2025 and beyond, with insights from third-party analysts and market experts
10:52, 22 January 2025
Ethereum price prediction: Third party data round up
What is the outlook for ETH as a long-term investment?
16:37, 7 January 2025People also watch
Still looking for a broker you can trust?
Join the 690,000+ traders worldwide that chose to trade with Capital.com